---
title: "GPU handling of OPC water in GROMACS yields matching physics and 1.6× speed-up"
id: "biorxiv-6-gpu-handling-of-opc-water-in-gromacs-validation-by-protein-folding-and-a-1-6"
canonical_url: "https://medichelpline.com/clinical-feed/biorxiv-6-gpu-handling-of-opc-water-in-gromacs-validation-by-protein-folding-and-a-1-6"
content_type: "clinical_feed_article"
specialty: "General"
source_name: "bioRxiv (Biomedical Preprints)"
source_url: "https://www.biorxiv.org/content/10.64898/2026.11.19.767864v1?rss=1"
published_at: "2026-11-20T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# GPU handling of OPC water in GROMACS yields matching physics and 1.6× speed-up
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/biorxiv-6-gpu-handling-of-opc-water-in-gromacs-validation-by-protein-folding-and-a-1-6
- **Specialty:** [General](https://medichelpline.com/clinical-feed/general.md)
- **Primary Source:** bioRxiv (Biomedical Preprints)
- **Source URL:** [Original Journal Publication](https://www.biorxiv.org/content/10.64898/2026.11.19.767864v1?rss=1)
- **Published At:** 2026-11-20T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- Investigators compared a modified GROMACS build that moves virtual-site coordinate updates to the **GPU** (Optimized) with the official release (Reference). The comparison focused on numerical agreement and physical observables. - The two builds placed the OPC virtual charge site with identical small error (2.3 x 10^-7 nm reported) and produced relative force differences below 10^-6, indicating tight numerical parity. - Five matched pairs of 5-microsecond folding simulations of the Trp-cage miniprotein were run to test folding outcomes and ensembles. The cohort showed folding in three of five Reference runs and in five of five Optimized runs (P = 0.44), and the folded ensembles matched. - Bulk water properties that distinguish **OPC** from TIP3P (density, diffusion coefficient, dielectric constant, and second hydration shell) were reproduced by both builds in these tests, according to the authors. - A production-scale test used a 166,826-atom membrane system containing the glucagon-like peptide-1 receptor. Residue hydration between the builds correlated strongly (r = 0.99). - Performance: Optimized ran 1.57–1.66 times as fast as a tuned Reference on two GPUs. The study team observed that 87–97% of the time saved came from moving the coordinate update to the **GPU**. - The authors reported no detectable alteration in physical behaviour across the tests performed. The source did not report details beyond these specific systems and metrics. - The study is a preprint and has not been peer-reviewed; the authors declared no competing interests. The repository for code is cited in the footnotes but the source did not report additional benchmarking environments or a broader set of force fields.
## Clinical Analysis & Structured Key Points
[](https://www.biorxiv.org/cdn-cgi/content?id=a4qb2YVfQnm8hSGyyUlz3SvpvnsqtjIU4LYvWOIIpR8-1795217212.724241-1.2.1.1-i9WU6FBgUTf2r01AZjtJxKuIKd_OKDT7rVS.rXOxKiLvUGmjjP5ZNScVC29RTp3x) [Skip to main content](https://www.biorxiv.org/content/10.64898/2026.11.19.767864v1?rss=1#main-content) [![bioRxiv](https://www.biorxiv.org/sites/default/files/biorxiv_article_logo.jpg)](https://www.biorxiv.org/) * [Home](https://www.biorxiv.org/) * [Submit](https://www.biorxiv.org/submit-a-manuscript) * [FAQ](https://www.biorxiv.org/about/FAQ) * [Blog](https://connect.biorxiv.org/news/) * [ALERTS / RSS](https://www.biorxiv.org/content/alertsrss) * [Resources](https://connect.biorxiv.org/resources/) * [About](https://www.biorxiv.org/content/about-biorxiv) * [Channels](https://www.biorxiv.org/content/10.64898/2026.11.19.767864v1?rss=1) * [4D Nucleome](https://connect.biorxiv.org/relate/content/66) * [Academia Sinica](https://connect.biorxiv.org/group/content/38) * [Advances in Genome Biology and Technology (AGBT) General Meeting 2016 #AGBT16](https://connect.biorxiv.org/relate/content/10) * [Albert Einstein College of Medicine](https://connect.biorxiv.org/group/content/4) * [Aligning Science Across Parkinson's (ASAP)](https://connect.biorxiv.org/relate/content/195) * [Allen Institute for Cell Science](https://connect.biorxiv.org/relate/content/71) * [Arc Institute](https://connect.biorxiv.org/relate/content/224) * [Babraham Institute](https://connect.biorxiv.org/relate/content/197) * [BICCN/BICAN](https://connect.biorxiv.org/relate/content/208) * [BioImaging North America](https://connect.biorxiv.org/relate/content/194) * [Biology of Genomes 2016 #BOG16](https://connect.biorxiv.org/relate/content/19) * [Breakthrough Discoveries for Thriving with Bipolar Disorder](https://connect.biorxiv.org/relate/content/236) * [Brown University](https://connect.biorxiv.org/group/content/9) * [California Institute of Technology](https://connect.biorxiv.org/group/content/32) * [Carnegie Mellon University](https://connect.biorxiv.org/group/content/19) * [Case Western Reserve University](https://connect.biorxiv.org/group/content/36) * [Central Oxford Structural Microscopy and Imaging](https://connect.biorxiv.org/relate/content/143) * [Centre for Microbiology and Environmental Systems Science](https://connect.biorxiv.org/relate/content/190) * [Chan Zuckerberg Biohub](https://connect.biorxiv.org/relate/content/121) * [Columbia University](https://connect.biorxiv.org/group/content/27) * [Donders Institute for Brain, Cognition and Behaviour](https://connect.biorxiv.org/relate/content/184) * [DREAM](https://connect.biorxiv.org/relate/content/153) * [Drug Development and Clinical Therapeutics](https://connect.biorxiv.org/relate/content/52) * [ENCODE](https://connect.biorxiv.org/relate/content/177) * [Ernst Strüngmann Institute (ESI) for Neuroscience](https://connect.biorxiv.org/relate/content/211) * [European Molecular Biology Laboratory (EMBL)](https://connect.biorxiv.org/relate/content/159) * [Francis Crick Institute](https://connect.biorxiv.org/relate/content/88) * [Fred Hutchinson Cancer Center](https://connect.biorxiv.org/group/content/28) * [Georgia Institute of Technology](https://connect.biorxiv.org/group/content/20) * [Harvard Program in Therapeutic Sciences](https://connect.biorxiv.org/relate/content/151) * [The Howard Hughes Medical Institute (HHMI)](https://connect.biorxiv.org/relate/content/227) * [Human Cell Atlas](https://connect.biorxiv.org/relate/content/163) * [Human Pangenome Reference Consortium (HPRC)](https://connect.biorxiv.org/relate/content/215) * [IMO Workshop](https://connect.biorxiv.org/relate/content/8) * [Impact of Genomic Variation on Function (IGVF)](https://connect.biorxiv.org/relate/content/214) * [Institut Pasteur](https://connect.biorxiv.org/relate/content/235/channel) * [Institute of Science and Technology Austria](https://connect.biorxiv.org/group/content/12) * [International Human Epigenome Consortium (IHEC)](https://connect.biorxiv.org/relate/content/219) * [International Mouse Phenotyping Consortium (IMPC)](https://connect.biorxiv.org/relate/content/185) * [Iowa State University](https://connect.biorxiv.org/group/content/6) * [Johns Hopkins University](https://connect.biorxiv.org/group/content/47) * [Mathematical Oncology](https://connect.biorxiv.org/relate/content/1) * [Micron Oxford](https://connect.biorxiv.org/relate/content/116) * [Michigan State University](https://connect.biorxiv.org/group/content/7) * [Morgridge Institute](https://connect.biorxiv.org/group/content/57) * [National Taiwan University](https://connect.biorxiv.org/group/content/39) * [NCI Cancer Systems Biology Consortium](https://connect.biorxiv.org/relate/content/210) * [NF Open Science Initiative](https://connect.biorxiv.org/relate/content/213) * [NCI Human Tumor Atlas Network](https://connect.biorxiv.org/relate/content/171) * [Neuromatch Conference](https://connect.biorxiv.org/relate/content/209) * [NeurotechEU](https://connect.biorxiv.org/relate/content/189) * [North Carolina State University](https://connect.biorxiv.org/group/content/37) * [Northeastern University](https://connect.biorxiv.org/group/content/54) * [Oregon Health & Sciences University](https://connect.biorxiv.org/group/content/22) * [RNA Therapeutics Institute at UMass Chan Med School](https://connect.biorxiv.org/relate/content/243) * [Rosetta Commons](https://connect.biorxiv.org/relate/content/191) * [Rutgers University](https://connect.biorxiv.org/group/content/31) * [SeroNet](https://connect.biorxiv.org/relate/content/192) * [Simons Foundation Autism Research Initiative (SFARI)](https://connect.biorxiv.org/relate/content/74) * [Society for Molecular Biology and Evolution #SMBE2016](https://connect.biorxiv.org/relate/content/29) * [Somatic Cell Genome Editing Program](https://connect.biorxiv.org/relate/content/167) * [Somatic Mosaicism across the Human Tissues Network](https://connect.biorxiv.org/relate/content/222) * [SPARC](https://connect.biorxiv.org/relate/content/187) * [Stowers Institute for Medical Research](https://connect.biorxiv.org/group/content/3) * [Stockholm University](https://connect.biorxiv.org/group/content/14) * [Tel Aviv University](https://connect.biorxiv.org/group/content/8) * [The Michael J. Fox Foundation](https://connect.biorxiv.org/relate/content/207) * [The Rockefeller University](https://connect.biorxiv.org/group/content/2) * [The Sainsbury Laboratory](https://connect.biorxiv.org/relate/content/98) * [The Whitehead Institute](https://connect.biorxiv.org/relate/content/212) * [University of Connecticut Health Center](https://connect.biorxiv.org/group/content/16) * [University of California, Berkeley](https://connect.biorxiv.org/group/content/13) * [University of California, San Diego](https://connect.biorxiv.org/group/content/41) * [University of California, San Francisco](https://connect.biorxiv.org/group/content/10) * [University of Chicago](https://connect.biorxiv.org/group/content/42) * [University of Geneva](https://connect.biorxiv.org/group/content/26) * [University of Guelph](https://connect.biorxiv.org/group/content/23) * [University of Hong Kong](https://connect.biorxiv.org/group/content/29) * [University of Illinois Chicago](https://connect.biorxiv.org/group/content/43) * [University of Iowa](https://connect.biorxiv.org/group/content/24) * [University of Kansas](https://connect.biorxiv.org/group/content/33) * [University of Massachusetts Chan Medical School](https://connect.biorxiv.org/group/content/44) * [University of New South Wales](https://connect.biorxiv.org/group/content/25) * [University of Ottawa](https://connect.biorxiv.org/group/content/35) * [University of Sydney](https://connect.biorxiv.org/group/content/50) * [Vanderbilt University](https://connect.biorxiv.org/group/content/30) * [Vienna BioCenter](https://connect.biorxiv.org/relate/content/186) * [Washington University in St. Louis](https://connect.biorxiv.org/group/content/11) * [Weizmann Institute of Science](https://connect.biorxiv.org/group/content/15) * [Yale University](https://connect.biorxiv.org/group/content/53) Search for this keyword [Advanced Search](https://www.biorxiv.org/search) New Results Follow this preprint # GPU handling of OPC water in GROMACS: validation by protein folding and a 1.6-fold speed-up [ View ORCID Profile](http://orcid.org/0009-0007-6621-7885)Takashi Kato, Nobuhiro Shojima, Toshimasa Yamauchi doi: https://doi.org/10.64898/2026.11.19.767864 This article is a preprint and has not been certified by peer review [[what does this mean?](https://www.biorxiv.org/about/FAQ#unrefereed)]. Takashi Kato Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Takashi%2BKato%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Kato%20T&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3ATakashi%2BKato%2B) * [ORCID record for Takashi Kato](http://orcid.org/0009-0007-6621-7885 "Open in new tab") * For correspondence: dmwa3773@g.ecc.u-tokyo.ac.jp Nobuhiro Shojima Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Nobuhiro%2BShojima%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Shojima%20N&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3ANobuhiro%2BShojima%2B) Toshimasa Yamauchi Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Toshimasa%2BYamauchi%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Yamauchi%20T&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AToshimasa%2BYamauchi%2B) * [Abstract](https://www.biorxiv.org/content/10.64898/2026.11.19.767864v1)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_art/node:5982069/1) * [Info/History](https://www.biorxiv.org/content/10.64898/2026.11.19.767864v1.article-info)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_info/node:5982069/1) * [Metrics](https://www.biorxiv.org/content/10.64898/2026.11.19.767864v1.article-metrics)[](https://www.biorxiv.org/panels_ajax_tab/article_tab_metrics/node:5982069/1) * [Supplementary material](https://www.biorxiv.org/content/10.64898/2026.11.19.767864v1.supplementary-material)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_data/node:5982069/1) * [Data/Code](https://www.biorxiv.org/content/10.64898/2026.11.19.767864v1.external-links)[](https://www.biorxiv.org/panels_ajax_tab/article_tab_data_code/node:5982069/1) * [ Preview PDF](https://www.biorxiv.org/content/10.64898/2026.11.19.767864v1.full.pdf+html)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:5982069/1) ![Loading](https://www.biorxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract Molecular dynamics (MD) simulation is one of the core computational methods of the life sciences, used to study protein folding, receptor activation and drug binding in atomic detail. The timescales it can reach depend on speed, and running each step entirely on a graphics processing unit (GPU) is now essential for fast simulation. Optimal Point Charge (OPC) water, recommended for the ff19SB protein force field, carries its negative charge on a virtual site, and in GROMACS 2026.3 virtual sites prevent the coordinate update from running on the GPU. The GROMACS developers have recently added GPU handling of virtual sites to the development version as an experimental feature. Whether simulations run in this way agree with the established CPU calculation has to be measured, and no such test has been reported over microseconds or in a membrane-protein system of production size. We compared a modified build that handles OPC sites within the GPU update (Optimized) with the official release (Reference). The two builds placed the charge site with the same error (2.3 x 10^-7 nm) and gave relative force differences below 10^-6. In five matched pairs of 5-microsecond simulations, the Trp-cage miniprotein folded with both builds (three of five Reference and five of five Optimized runs; P = 0.44), and the folded ensembles matched. Both builds reproduced the density, diffusion coefficient, dielectric constant and second hydration shell that distinguish OPC from TIP3P water. In a 166,826-atom membrane system of the glucagon-like peptide-1 receptor, residue hydration agreed between the builds (r = 0.99), and Optimized ran 1.57-1.66 times as fast as tuned Reference on two GPUs, with 87-97% of the time saved coming from moving the coordinate update to the GPU. In these tests, GPU handling of OPC sites gave a substantial speed gain with no sign of altered physical behaviour. ### Competing Interest Statement The authors have declared no competing interest. ## Footnotes * Copyright The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a [CC-BY 4.0 International license](http://creativecommons.org/licenses/by/4.0/). bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.biorxiv.org/content/10.64898/2026.11.19.767864v1?rss=1#page) [ Previous](https://www.biorxiv.org/content/10.64898/2026.11.19.767971v1 "Two novel plant-derived yeast species in Thailandicola \(Microbotryomycetes\): comparative genomics and transformation")[Next ](https://www.biorxiv.org/content/10.64898/2026.11.19.767785v1 "A midnight snack for spirulina: a dual-substrate kinetic model for second cheese whey supplementation of Arthrospira platensis") Posted November 20, 2026. [ Download PDF](https://www.biorxiv.org/content/10.64898/2026.11.19.767864v1.full.pdf) Print/Save Options [Download PDF](https://www.biorxiv.org/content/biorxiv/early/2026/11/20/2026.11.19.767864.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.biorxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [Supplementary Material ](https://www.biorxiv.org/content/10.64898/2026.11.19.767864v1.supplementary-material) [ Data/Code](https://www.biorxiv.org/content/early/2026/11/20/2026.11.19.767864.external-links) [ Email](https://www.biorxiv.org/ "Email this Article") [ Share](https://www.biorxiv.org/) GPU handling of OPC water in GROMACS: validation by protein folding and a 1.6-fold speed-up Takashi Kato, Nobuhiro Shojima, Toshimasa Yamauchi bioRxiv 2026.11.19.767864; doi: https://doi.org/10.64898/2026.11.19.767864 This article is a preprint and has not been certified by peer review [[what does this mean?](https://www.biorxiv.org/about/FAQ#unrefereed)]. Share This Article: Copy [![Twitter logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.biorxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.11.19.767864v1%26text%3DGPU%2520handling%2520of%2520OPC%2520water%2520in%2520GROMACS%253A%2520validation%2520by%2520protein%2520folding%2520and%2520a%25201.6-fold%2520speed-up "Share this on Twitter") [![Facebook logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.biorxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.11.19.767864v1%26t%3DGPU%2520handling%2520of%2520OPC%2520water%2520in%2520GROMACS%253A%2520validation%2520by%2520protein%2520folding%2520and%2520a%25201.6-fold%2520speed-up "Share on Facebook") [![LinkedIn logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.biorxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.11.19.767864v1%26title%3DGPU%2520handling%2520of%2520OPC%2520water%2520in%2520GROMACS%253A%2520validation%2520by%2520protein%2520folding%2520and%2520a%25201.6-fold%2520speed-up%26summary%3D%26source%3DbioRxiv "Publish this post to LinkedIn") [![Mendeley logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png)](https://www.biorxiv.org/highwire_log/share/mendeley?link=http%3A%2F%2Fwww.mendeley.com%2Fimport%2F%3Furl%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.11.19.767864v1%26title%3DGPU%2520handling%2520of%2520OPC%2520water%2520in%2520GROMACS%253A%2520validation%2520by%2520protein%2520folding%2520and%2520a%25201.6-fold%2520speed-up "Share on Mendeley") [ Citation Tools](https://www.biorxiv.org/ "Citation Tools") [ Get QR code](https://connect.biorxiv.org/qr/2026.11.19.767864) * [Tweet Widget](http://twitter.com/share?url=https%3A//www.biorxiv.org/content/10.64898/2026.11.19.767864v1&count=horizontal&via=&text=GPU%20handling%20of%20OPC%20water%20in%20GROMACS%3A%20validation%20by%20protein%20folding%20and%20a%201.6-fold%20speed-up&counturl=www.biorxiv.org/content/10.64898/2026.11.19.767864v1 "Tweet This") Reviews and Context 0 Comment 0 TRIP Peer Reviews 0 Community Reviews 0 Automated Services 0 Blogs/Media 0 Author Videos **Subject Areas** [**All Articles**](https://www.biorxiv.org/content/early/recent) * [Animal Behavior and Cognition](https://www.biorxiv.org/collection/animal-behavior-and-cognition) (8164) * [Biochemistry](https://www.biorxiv.org/collection/biochemistry) (19027) * [Bioengineering](https://www.biorxiv.org/collection/bioengineering) (15171) * [Bioinformatics](https://www.biorxiv.org/collection/bioinformatics) (46171) * [Biophysics](https://www.biorxiv.org/collection/biophysics) (22958) * [Cancer Biology](https://www.biorxiv.org/collection/cancer-biology) (20385) * [Cell Biology](https://www.biorxiv.org/collection/cell-biology) (27663) * [Clinical Trials](https://www.biorxiv.org/collection/clinical-trials) (138) * [Developmental Biology](https://www.biorxiv.org/collection/developmental-biology) (14303) * [Ecology](https://www.biorxiv.org/collection/ecology) (21654) * [Epidemiology](https://www.biorxiv.org/collection/epidemiology) (2067) * [Evolutionary Biology](https://www.biorxiv.org/collection/evolutionary-biology) (26065) * [Genetics](https://www.biorxiv.org/collection/genetics) (16505) * [Genomics](https://www.biorxiv.org/collection/genomics)
## Related Clinical Research

- [Arts engagement and global wellbeing: Outcome-wide analysis from 22 countries](https://medichelpline.com/clinical-feed/medrxiv-9-the-health-and-wellbeing-impact-of-arts-engagement-a-longitudinal-outcome-wide.md)
- [REMI: Free tool enabling truncated proximity searches in PubMed](https://medichelpline.com/clinical-feed/medrxiv-23-remi-a-free-tool-for-truncated-proximity-searching-in-pubmed.md)
- [Creatine for Healthy Aging: Examining a Decade of Use](https://medichelpline.com/clinical-feed/medical-news-today-0-age-appropriate-i-ve-taken-creatine-for-10-years-does-it-help-healthy-aging.md)
- [Saturated Fats Linked to Inflammation in Ketogenic Diet: Insights from Mouse Study](https://medichelpline.com/clinical-feed/medical-news-today-0-certain-saturated-fats-may-turn-a-ketogenic-diet-inflammatory-mice-study.md)
- [Community management of delirium: diagnosis, investigation, and home-based care](https://medichelpline.com/clinical-feed/bmj-2-practice-pointer-community-management-of-delirium.md)

## Navigation
- [← Back to General Feed](https://medichelpline.com/clinical-feed/general.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.